Louisiana State Employees Retirement System purchased a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) in the first quarter, Holdings Channel.com reports. The fund purchased 73,100 shares of the real estate investment trust’s stock, valued at approximately $1,406,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Silver Oak Securities Incorporated lifted its position in shares of Sabra Healthcare REIT by 2.9% during the first quarter. Silver Oak Securities Incorporated now owns 25,855 shares of the real estate investment trust’s stock valued at $497,000 after purchasing an additional 725 shares in the last quarter. Montecito Bank & Trust increased its stake in Sabra Healthcare REIT by 4.7% in the 1st quarter. Montecito Bank & Trust now owns 41,880 shares of the real estate investment trust’s stock valued at $805,000 after buying an additional 1,880 shares during the last quarter. Rockefeller Capital Management L.P. increased its stake in Sabra Healthcare REIT by 16.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 16,674 shares of the real estate investment trust’s stock valued at $316,000 after buying an additional 2,378 shares during the last quarter. Corient Private Wealth LLC bought a new position in shares of Sabra Healthcare REIT during the 4th quarter worth approximately $266,000. Finally, Hsbc Holdings PLC lifted its position in shares of Sabra Healthcare REIT by 19.7% during the 4th quarter. Hsbc Holdings PLC now owns 514,409 shares of the real estate investment trust’s stock worth $9,738,000 after buying an additional 84,784 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on the company. Truist Financial upped their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Weiss Ratings cut Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. UBS Group set a $19.00 price objective on Sabra Healthcare REIT in a research note on Thursday, June 18th. Wells Fargo & Company raised their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Finally, Citigroup cut Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $24.00 to $19.00 in a research note on Monday, June 22nd. Four analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT currently has a consensus rating of “Hold” and a consensus target price of $21.30.
Sabra Healthcare REIT Trading Up 2.4%
Shares of SBRA stock opened at $20.16 on Friday. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. The firm has a market cap of $5.08 billion, a P/E ratio of 32.00, a PEG ratio of 1.47 and a beta of 0.65. The company has a 50 day moving average of $19.70 and a 200-day moving average of $19.66. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $21.28.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. During the same quarter in the prior year, the business earned $0.37 earnings per share. Sabra Healthcare REIT’s revenue for the quarter was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.
Sabra Healthcare REIT Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.0%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 190.48%.
Sabra Healthcare REIT Profile
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
See Also
- Five stocks we like better than Sabra Healthcare REIT
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
